Capital International Inc’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Capital International Inc’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,942,807	Closed	-$6.77M	–	310
2022 Q4	$6.77M	Sell	2,942,807 -73,564	-2%	-$225K	0.15%	152
2022 Q3	$9.71M	Buy	3,016,371 +22,676	+0.8%	+$73.8K	0.22%	122
2022 Q2	$16.5M	Buy	2,993,695 +658,219	+28%	+$2.05M	0.23%	127
2022 Q1	$5.44M	Buy	2,335,476 +584,769	+33%	+$1.99M	0.06%	180
2021 Q4	$10.6M	Buy	1,750,707 +589,816	+51%	+$5.67M	0.1%	165
2021 Q3	$16.1M	Buy	1,160,891 +163,653	+16%	+$1.93M	0.16%	138
2021 Q2	$13M	Buy	997,238 +114,470	+13%	+$1.53M	0.12%	148
2021 Q1	$13.6M	Buy	+882,768	New	+$20.8M	0.13%	147

Other funds holding GRCL

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Capital International Inc's GRCL Position: Q1 2023 in Review

Capital International Inc sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2023, closing a stake of 2,942,807 shares — an estimated $6.77M sold.

Capital International Inc first reported a position in GRCL in Q1 2021 and held it in 8 quarters. The position peaked at $16.5M in Q2 2022. 33 funds tracked by Wall St. Rank hold GRCL as of Q1 2023.

Capital International Inc reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Capital International Inc sold 2,942,807 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2023, an estimated $6.77M.
Capital International Inc first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q1 2021 and held it in 8 quarters.
Capital International Inc's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $16.5M in Q2 2022.
33 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2023.

Based on Capital International Inc's 13F filing for Q1 2023, filed 15 May 2023.